{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
    },
    "path": "hypoxia/zhang2011.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "key": "e46464f8a12cefeb9bf4541b31ff8cfe",
      "relation": "partOf",
      "source": 111,
      "target": 54
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "9fce8e0399471d34be2309e005cf72dd",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 25
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 activation promotes cellular response to low oxygen, reduced glucose supply, and oxidative stress.",
      "key": "c67110b791014a2a5a5239a166b95f8a",
      "line": 362,
      "relation": "increases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 31
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 activation promotes cellular response to low oxygen, reduced glucose supply, and oxidative stress.",
      "key": "da2c848ab08bac0b7ffaa89d13ca677f",
      "line": 363,
      "relation": "increases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "1fd1131414f7e1c112016f914a4111c6",
      "line": 400,
      "relation": "increases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 44
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "c332dc762069c0661af5d1c7e6004740",
      "line": 401,
      "relation": "increases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 41
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "0c2a00fe14b4a446d29f40d8e5a78bd5",
      "line": 402,
      "relation": "decreases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "dc19b9fa2f1015770f27331396c5a113",
      "line": 403,
      "relation": "decreases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 116
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "PC12",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          },
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "7381457b79b02d6afce3a23d42493994",
      "line": 438,
      "relation": "negativeCorrelation",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 117
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "a6b99edcb5c675e4b5bc5c8ae20a69eb",
      "line": 482,
      "relation": "decreases",
      "source": 111,
      "target": 117
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "5b391d15a42b3175d5d51516ed51050d",
      "line": 480,
      "relation": "increases",
      "source": 111,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "3ea450e07490812dec4d4dd724f4f1fe",
      "line": 481,
      "relation": "increases",
      "source": 111,
      "target": 14,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "cf3bfe238e15731c26d82075635c2cd1",
      "line": 554,
      "relation": "increases",
      "source": 111,
      "target": 9
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "c25381ed8dd416b0555a23212ec05a67",
      "line": 555,
      "relation": "increases",
      "source": 111,
      "target": 11
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "bb301954a5e9740e4c72253e27e14030",
      "line": 556,
      "relation": "increases",
      "source": 111,
      "target": 43
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, increasing HIF-1 activity may prevent neurons from mutant huntingtin protein damage.",
      "key": "3934a124f70a0291b0a3322df5213ffb",
      "line": 561,
      "relation": "decreases",
      "source": 111,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 95,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, HIF-1 induction may provide cytoprotection by increasing energy supply and contributing to cellular redox homeostasis.",
      "key": "7b9a4e0ac92d0dde44ec5ea5d2556d6f",
      "line": 583,
      "relation": "increases",
      "source": 111,
      "target": 29
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "edb11c8d749c28a6cf19d6f846752ed5",
      "line": 647,
      "relation": "increases",
      "source": 111,
      "target": 76
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "44d0d99b46c523b4a9a7e0cca7a2a146",
      "line": 648,
      "relation": "increases",
      "source": 111,
      "target": 106
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "b652d8feb2b5c054e81974c9a39b9301",
      "line": 649,
      "relation": "increases",
      "source": 111,
      "target": 71
    },
    {
      "key": "5ac62b5a06a2e29b29a97d25e0ae3951",
      "relation": "partOf",
      "source": 80,
      "target": 111
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activity of HIF-1 is mainly controlled through regulating the protein level of HIF-1α [3].",
      "key": "772ea49b8a84f4fc70ae64e3447bd912",
      "line": 104,
      "relation": "regulates",
      "source": 80,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "293d7af70873d72e5ee6a975a372f10e",
      "relation": "partOf",
      "source": 80,
      "target": 49
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "005d1ed98b5e42a0a48b3d183e476e47",
      "line": 92,
      "relation": "increases",
      "source": 80,
      "source_modifier": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "target": 49,
      "target_modifier": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      }
    },
    {
      "key": "28223f5e1ff992af4e4ba901a398e63e",
      "relation": "hasVariant",
      "source": 80,
      "target": 90
    },
    {
      "key": "7b3b5e35c302235858777bc99ff556ae",
      "relation": "hasVariant",
      "source": 80,
      "target": 91
    },
    {
      "key": "f3a85755ac4a654e41b2ee5ab98fefca",
      "relation": "partOf",
      "source": 80,
      "target": 52
    },
    {
      "key": "f4684b1fcd731e2680b57a250d0f7db7",
      "relation": "hasVariant",
      "source": 80,
      "target": 85
    },
    {
      "key": "158834ecdc3900dc2da2d01e74f4e9eb",
      "relation": "hasVariant",
      "source": 80,
      "target": 89
    },
    {
      "key": "dbb3daf9fa8226bd47f5c89fc25d777d",
      "relation": "partOf",
      "source": 80,
      "target": 50
    },
    {
      "key": "e71fee122f99e5c3b16784856b76ed2d",
      "relation": "partOf",
      "source": 80,
      "target": 51
    },
    {
      "key": "d5708cc3f6d9b1739badfb0711561c58",
      "relation": "hasVariant",
      "source": 80,
      "target": 84
    },
    {
      "key": "2ed2a2af884849ce7f32b68d09e36747",
      "relation": "hasVariant",
      "source": 80,
      "target": 92
    },
    {
      "key": "2d3c31dd42ab16d49824ce5ed28bffc8",
      "relation": "hasVariant",
      "source": 80,
      "target": 83
    },
    {
      "key": "2cf849ca82fb77848b3db377738303d1",
      "relation": "hasVariant",
      "source": 80,
      "target": 82
    },
    {
      "key": "8ec125ceb1ce750c74b3e9db3099f339",
      "relation": "hasVariant",
      "source": 80,
      "target": 81
    },
    {
      "key": "0269f10a10de1492bd2c2e64dac5b919",
      "relation": "partOf",
      "source": 80,
      "target": 48
    },
    {
      "key": "1af90b4d5b8ee7247adc3649bac4ed61",
      "relation": "hasVariant",
      "source": 80,
      "target": 87
    },
    {
      "key": "ec83a79782f591bde7e9ab9b39fe46ec",
      "relation": "hasVariant",
      "source": 80,
      "target": 88
    },
    {
      "key": "a462cad8384e4711cada9be1c696e2c1",
      "relation": "hasVariant",
      "source": 80,
      "target": 86
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "B12 cell",
            "namespace": "CellLine"
          },
          {
            "identifier": "PC12",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Overexpression of HIF-1α has been shown to protect the rat sympathetic nerves-like cell line PC12, the central nervous system cell line B12, and primary cultured cortical neurons from Aβ-induced neurotoxicity [58], possibly through activating glycolytic and hexose monophosphate shunt-related enzymes.",
      "key": "0c1da6666919a20afef59899cba2904c",
      "line": 349,
      "relation": "increases",
      "source": 80,
      "target": 35
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "B12 cell",
            "namespace": "CellLine"
          },
          {
            "identifier": "PC12",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Overexpression of HIF-1α has been shown to protect the rat sympathetic nerves-like cell line PC12, the central nervous system cell line B12, and primary cultured cortical neurons from Aβ-induced neurotoxicity [58], possibly through activating glycolytic and hexose monophosphate shunt-related enzymes.",
      "key": "e62fb6949625e45a29ab69d33efd6f6c",
      "line": 350,
      "relation": "increases",
      "source": 80,
      "target": 39
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "ddf62ec8802ff90c3d62666c156b021b",
      "line": 416,
      "relation": "increases",
      "source": 80,
      "target": 101
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "930749d52013616ba040abcec4057149",
      "line": 417,
      "relation": "increases",
      "source": 80,
      "target": 102
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "03fdc260da6b8dbfc2da41589d6ca7dd",
      "line": 418,
      "relation": "decreases",
      "source": 80,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Meanwhile, a conditional knock-down of HIF-1α in mice results in a 40% decrease of TH expression in substantia nigra [86].",
      "key": "8a4ce2630c9e4563001c7a679d0530fd",
      "line": 460,
      "relation": "increases",
      "source": 80,
      "target": 137
    },
    {
      "key": "d17058660ca5f793810b2657ee8aeb8b",
      "relation": "partOf",
      "source": 68,
      "target": 111
    },
    {
      "key": "84f40c4ae5e51e45d9490f2c5c39ecb4",
      "relation": "partOf",
      "source": 68,
      "target": 49
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The bHLH and PAS motifs are required for dimerization between HIF-1α and HIF-1β.",
      "key": "d991141b6fb8fdee56cf6237eeb07300",
      "line": 86,
      "relation": "increases",
      "source": 108,
      "target": 111
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The bHLH and PAS motifs are required for dimerization between HIF-1α and HIF-1β.",
      "key": "32c79c217e2d0882f85c0dbfcb8a0a80",
      "line": 87,
      "relation": "increases",
      "source": 115,
      "target": 111
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "7e0129bb3659f06432d2899bab455f97",
      "line": 91,
      "relation": "increases",
      "source": 40,
      "target": 80,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "50d7f59d832762c8b5e0a2a456fc7939",
      "line": 218,
      "relation": "increases",
      "source": 40,
      "target": 100,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF can induce angiogenesis and increase blood supply to motor neurons during hypoxia through action on endothelial cells [39].",
      "key": "2d608fe3f13368e8a4c824d83e6c41f5",
      "line": 248,
      "relation": "increases",
      "source": 40,
      "target": 106,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "1241e609f3ff667f7ee6dd0a3cf8fbd7",
      "line": 289,
      "relation": "increases",
      "source": 40,
      "target": 28
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "b3fe18524d8e976c2b2388d1806c6852",
      "line": 93,
      "relation": "increases",
      "source": 49,
      "source_modifier": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activated HIF-1 complex subsequently binds to hypoxic response elements (HREs) in the regulatory regions of genes and recruits co-transactivation factors such as CBP/p300 [CBP: CREB (cAMP-response element-binding protein)-binding protein/E1A-binding protein].",
      "key": "a55cde83103e7fcd82a7f2687396b26f",
      "line": 100,
      "relation": "increases",
      "source": 54,
      "target": 72
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activated HIF-1 complex subsequently binds to hypoxic response elements (HREs) in the regulatory regions of genes and recruits co-transactivation factors such as CBP/p300 [CBP: CREB (cAMP-response element-binding protein)-binding protein/E1A-binding protein].",
      "key": "a731a27c01e76ba3f0cec73ec7ac69f2",
      "line": 101,
      "relation": "increases",
      "source": 54,
      "target": 77
    },
    {
      "key": "c7d46a2f48ce313c6cc50411488be939",
      "relation": "partOf",
      "source": 113,
      "target": 54
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "ALS-like symptoms and neuropathology can be produced in mice by a targeted deletion of the hypoxia response element that eliminates the expression of VEGF in response to hypoxia [42].",
      "key": "8563c3058d71665fbb88990212d8f819",
      "line": 262,
      "relation": "increases",
      "source": 113,
      "target": 106
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "ALS-like symptoms and neuropathology can be produced in mice by a targeted deletion of the hypoxia response element that eliminates the expression of VEGF in response to hypoxia [42].",
      "key": "d009e605518e34f3de4d55749164d6c9",
      "line": 263,
      "relation": "decreases",
      "source": 113,
      "target": 122
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "b578fb8a0946315bb35875cb4666ca8a",
      "line": 271,
      "relation": "negativeCorrelation",
      "source": 113,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "key": "180add1b5c8d474f03802ec71e313f71",
      "relation": "partOf",
      "source": 113,
      "target": 64
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Promoter activity studies suggest that the TH gene is under the control of a hypoxia response element [82–83].",
      "key": "a1f94edfe16c5ede19b537cdf26bb053",
      "line": 445,
      "relation": "regulates",
      "source": 113,
      "target": 137
    },
    {
      "key": "d4d942122a381491acf676f522163e41",
      "relation": "partOf",
      "source": 72,
      "target": 50
    },
    {
      "key": "c45464c4fa4fbb8bc217047b1ab61a3e",
      "relation": "partOf",
      "source": 77,
      "target": 51
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "076f94e6ee92556fc032d81c03c16323",
      "line": 109,
      "relation": "increases",
      "source": 74,
      "target": 90
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "f096b265b314928ed3247b5e19f0466f",
      "line": 110,
      "relation": "increases",
      "source": 74,
      "target": 91
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "ac58ae2b67b4bb82f7cb4960736c21fa",
      "line": 124,
      "relation": "increases",
      "source": 90,
      "target": 52
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "d5e06b60f2c7fa1b5d47ee9268d14c86",
      "line": 111,
      "relation": "increases",
      "source": 73,
      "target": 90
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "c85962ca957565e923d11db6ee8b1d24",
      "line": 112,
      "relation": "increases",
      "source": 73,
      "target": 91
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "60a63ad3a1678068f000d24316b3cca6",
      "line": 113,
      "relation": "increases",
      "source": 75,
      "target": 90
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "7e38fca3cc84ade0b3eee8abf6387361",
      "line": 114,
      "relation": "increases",
      "source": 75,
      "target": 91
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "044eb696f29774aae5445ce4b67ede13",
      "line": 117,
      "relation": "increases",
      "source": 55,
      "target": 74,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "c3568eeb01383f01e6103faac1e9fd62",
      "line": 118,
      "relation": "increases",
      "source": 55,
      "target": 73,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "e39abc3b6b4350d1076a9f53c78b0d11",
      "line": 119,
      "relation": "increases",
      "source": 55,
      "target": 75,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "c329e4b004f823c70a7fcfa53c7a89b7",
      "relation": "partOf",
      "source": 1,
      "target": 55
    },
    {
      "key": "7f30d83445f69ceaf7c3e3af18e36f4c",
      "relation": "partOf",
      "source": 7,
      "target": 55
    },
    {
      "key": "68253ed71cfc70c6136bd015060201ac",
      "relation": "partOf",
      "source": 7,
      "target": 56
    },
    {
      "key": "98179097740f85449323b8930a472e92",
      "relation": "partOf",
      "source": 7,
      "target": 57
    },
    {
      "key": "805e4722e3aabf647fdcd39db424d8f4",
      "relation": "partOf",
      "source": 13,
      "target": 55
    },
    {
      "key": "c4f7cce68ee9f11c8b45dd08b7d3738a",
      "relation": "partOf",
      "source": 13,
      "target": 58
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "14495123cce3a5a3b302a010364ef8b1",
      "line": 126,
      "relation": "increases",
      "source": 52,
      "target": 85
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "c96151d9d4190cd56c17bd88bb18eabf",
      "line": 153,
      "relation": "increases",
      "source": 52,
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "key": "e43195aafb4762ff3f9c030602a09f81",
      "relation": "partOf",
      "source": 107,
      "target": 52
    },
    {
      "key": "f8e363aec6f657975002bcc1d92ffa47",
      "relation": "partOf",
      "source": 85,
      "target": 63
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "c6760c4548aa91bbb14ed57127be157d",
      "line": 127,
      "relation": "increases",
      "source": 85,
      "target": 63
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "a144b4e1c37adff39ca87981ef5c7d87",
      "line": 128,
      "relation": "increases",
      "source": 63,
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "key": "83a5bc2a35dee3057398ac0ccd9a2c17",
      "relation": "partOf",
      "source": 114,
      "target": 63
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "e484d691d1de6bd6825ed15da310bcb9",
      "line": 133,
      "relation": "decreases",
      "source": 6,
      "target": 74
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "47126cff1d06be227d02529a074ce782",
      "line": 134,
      "relation": "decreases",
      "source": 6,
      "target": 73
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "09ea26625ad23fe191abad3d16f6e305",
      "line": 135,
      "relation": "decreases",
      "source": 6,
      "target": 75
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "1f8b2f8e6208b6f894c554d6a92eacd2",
      "line": 136,
      "relation": "increases",
      "source": 6,
      "target": 134
    },
    {
      "key": "ca4d655fb439cd36292b57f58bfb09e5",
      "relation": "partOf",
      "source": 6,
      "target": 56
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "813bcf2643b1e51dabcc7b80bf4dd6fc",
      "line": 142,
      "relation": "increases",
      "source": 58,
      "target": 89
    },
    {
      "key": "c8008a6e02c772b72dcf91c13aee949c",
      "relation": "partOf",
      "source": 93,
      "target": 58
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "11735f7570698a2eb038fa16fcd66e16",
      "line": 143,
      "relation": "decreases",
      "source": 89,
      "target": 50
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "6a8d41cdabfe57b4b401a7b51035807f",
      "line": 144,
      "relation": "decreases",
      "source": 89,
      "target": 51
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "82ad17a8d420574cf92b212aa5b3d04d",
      "line": 145,
      "relation": "decreases",
      "source": 89,
      "target": 72,
      "target_modifier": {
        "effect": {
          "identifier": "0001071",
          "name": "nucleic acid binding transcription factor activity",
          "namespace": "go"
        },
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "17e1ed406386975dc0bc95155e8adafb",
      "line": 146,
      "relation": "decreases",
      "source": 89,
      "target": 77,
      "target_modifier": {
        "effect": {
          "identifier": "0001071",
          "name": "nucleic acid binding transcription factor activity",
          "namespace": "go"
        },
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "15554f675b2c9d27c40f387220ede477",
      "line": 150,
      "relation": "increases",
      "source": 98,
      "target": 84
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "f4f6ff6a629b0a3e27b84a8c00ac0061",
      "line": 152,
      "relation": "increases",
      "source": 98,
      "target": 52
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "4af1169a88f3dfabd8c445cde8418be9",
      "line": 154,
      "relation": "increases",
      "source": 98,
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "2ac35d0acacd3a88238d12e1c15d64b1",
      "line": 151,
      "relation": "increases",
      "source": 84,
      "target": 52
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Mutation of lysine 532 to arginine has been reported to result in increased stability of overexpressed HIF-1α [22].",
      "key": "b37c5c8e8fe6684c19d0f203b49b4113",
      "line": 157,
      "relation": "increases",
      "source": 92,
      "target": 80
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Direct phosphorylation on threonine 796 by mitogen-activated protein kinase (MAPK) has recently been identified as a novel modification on HIF-1α and is able to increase HIF-1 activity [23].",
      "key": "7a58477e26bc81707659e1a202e2149a",
      "line": 162,
      "relation": "increases",
      "source": 109,
      "target": 83
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Direct phosphorylation on threonine 796 by mitogen-activated protein kinase (MAPK) has recently been identified as a novel modification on HIF-1α and is able to increase HIF-1 activity [23].",
      "key": "99388d64c8cab7b64e53a0e4861a3d99",
      "line": 163,
      "relation": "increases",
      "source": 109,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "One mechanism to explain the increased transcriptional activity is that HIF-1β binds preferentially to the phosphorylated form of HIF-1α [24].",
      "key": "1e56f0ebf44fcb4f2ae1627377f7ff15",
      "line": 166,
      "relation": "increases",
      "source": 83,
      "target": 49
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, it has been reported that phosphorylation at T796 in HIF-1α increases the affinity of the interaction between HIF-1α and the transcriptional co-activator CBP/p300 [25].",
      "key": "2e9f3d411217aab8aa34c7e465957f0e",
      "line": 171,
      "relation": "increases",
      "source": 83,
      "target": 50
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, it has been reported that phosphorylation at T796 in HIF-1α increases the affinity of the interaction between HIF-1α and the transcriptional co-activator CBP/p300 [25].",
      "key": "60636ebd38bf42079bedaa06cd1181d1",
      "line": 172,
      "relation": "increases",
      "source": 83,
      "target": 51
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Consistent with this, it is found that phosphorylation of T796 prevents the hydroxylation of N803 by FIH [25].",
      "key": "9fc9419ff7404eb82957fee935c3777b",
      "line": 176,
      "relation": "decreases",
      "source": 83,
      "target": 93,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Consistent with this, it is found that phosphorylation of T796 prevents the hydroxylation of N803 by FIH [25].",
      "key": "050abed51c3354a43fa4cc665860b770",
      "line": 177,
      "relation": "decreases",
      "source": 83,
      "target": 89
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Inhibition of these phosphorylation sites has been shown to impair both transcriptional activity and the nuclear localization of HIF-1α [26].",
      "key": "1f1eecb9b48edb56a988d90798bf3f2a",
      "line": 181,
      "relation": "increases",
      "source": 83,
      "target": 80,
      "target_modifier": {
        "effect": {
          "identifier": "0001071",
          "name": "nucleic acid binding transcription factor activity",
          "namespace": "go"
        },
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Inhibition of these phosphorylation sites has been shown to impair both transcriptional activity and the nuclear localization of HIF-1α [26].",
      "key": "14bfa77f4c28e9800d387b048c2cd591",
      "line": 182,
      "relation": "increases",
      "source": 83,
      "target": 80,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, phosphorylation of HIF-1α by glycogen synthase kinase (GSK)-3β may target HIF-1α for proteasomal degradation [26].",
      "key": "27757335782595c99958e37ba4e4eb6a",
      "line": 186,
      "relation": "increases",
      "source": 79,
      "target": 82
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, phosphorylation of HIF-1α by glycogen synthase kinase (GSK)-3β may target HIF-1α for proteasomal degradation [26].",
      "key": "e52bcda2453088a90681f80d208e0261",
      "line": 187,
      "relation": "increases",
      "source": 82,
      "source_modifier": {
        "effect": {
          "name": "proteasome binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxyl radical and hydrogen peroxide can destabilize HIF-1α protein in both normoxic and hypoxic conditions [27–28].",
      "key": "da4a5a1e43e560ac72defa98cb975bf8",
      "line": 191,
      "relation": "decreases",
      "source": 15,
      "target": 80
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxyl radical and hydrogen peroxide can destabilize HIF-1α protein in both normoxic and hypoxic conditions [27–28].",
      "key": "de8bd834792fe129948410d7a4a5eb6a",
      "line": 192,
      "relation": "decreases",
      "source": 5,
      "target": 80
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The oxidized HIF-1α protein might be recognized and degraded by the ubiquitin-independent 20S proteasomal pathway, which primarily degrades cellular oxidized proteins under oxidative stress conditions [29].",
      "key": "df838b49d6b4abca0b511055cadab6f4",
      "line": 198,
      "relation": "increases",
      "source": 81,
      "target": 48
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The oxidized HIF-1α protein might be recognized and degraded by the ubiquitin-independent 20S proteasomal pathway, which primarily degrades cellular oxidized proteins under oxidative stress conditions [29].",
      "key": "c7bdb936ff65ab0d4caf3cf7e26ffd45",
      "line": 199,
      "relation": "increases",
      "source": 48,
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "key": "a43758ec269a4d81cb9d72b689be5657",
      "relation": "partOf",
      "source": 20,
      "target": 48
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "367973b0ee76c7f34ccc9c29129681dd",
      "line": 205,
      "relation": "increases",
      "source": 87,
      "target": 80
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "b4a6b886d99434b348ac5fd57c74de53",
      "line": 206,
      "relation": "increases",
      "source": 88,
      "target": 50
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "31270baf2ed4cfac2341468d065b1bb4",
      "line": 207,
      "relation": "increases",
      "source": 88,
      "target": 51
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "e2f37d09263803f494e94f1e1acc3519",
      "line": 208,
      "relation": "increases",
      "source": 88,
      "target": 80,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Sumoylation of HIF-1α has been reported to regulate its protein level and transcriptional activity.",
      "key": "06604a4cd60fa4bec29af3f822aa0479",
      "line": 212,
      "relation": "regulates",
      "source": 86,
      "target": 134
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Sumoylation of HIF-1α has been reported to regulate its protein level and transcriptional activity.",
      "key": "7b33f088a69047feea88a3bc13f7c345",
      "line": 213,
      "relation": "regulates",
      "source": 86,
      "target": 80,
      "target_modifier": {
        "effect": {
          "identifier": "0001071",
          "name": "nucleic acid binding transcription factor activity",
          "namespace": "go"
        },
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "7415949d240582f1b16bc62001a22a92",
      "line": 221,
      "relation": "increases",
      "source": 86,
      "target": 80
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "019ca0890ac010abc850726ec49aff46",
      "line": 219,
      "relation": "increases",
      "source": 100,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 105,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "270d7d8b6298ac7e97658b3862150d0f",
      "line": 220,
      "relation": "increases",
      "source": 105,
      "target": 86
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "However, desumoylation by SUMO-Specific Protease 1 (SENP-1) has been shown to be essential for the stabilization of HIF-1α [33].",
      "key": "4042daa6953e14f0fe635b4ac57823fb",
      "line": 226,
      "relation": "decreases",
      "source": 110,
      "target": 86
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "However, desumoylation by SUMO-Specific Protease 1 (SENP-1) has been shown to be essential for the stabilization of HIF-1α [33].",
      "key": "7aec162a0a2d2bdcc20b16bf1b849fbc",
      "line": 227,
      "relation": "regulates",
      "source": 110,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "03748145698e9c362c3759d862d6fb09",
      "line": 236,
      "relation": "negativeCorrelation",
      "source": 120,
      "target": 32
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "6ed258407b68eac366a1951d39ead329",
      "line": 239,
      "relation": "increases",
      "source": 120,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "4648540f5bdde415b59a0632dcfb67ef",
      "line": 236,
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 120
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "dfbad561a152f0cab8e05a2169fdb010",
      "line": 237,
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 125
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "43ff6e21ed11fda10bd5ea263f4393a0",
      "line": 238,
      "relation": "decreases",
      "source": 32,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "623bec7b7becd714154b4733a35846b2",
      "line": 237,
      "relation": "negativeCorrelation",
      "source": 125,
      "target": 32
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "01a94ddfbb3342c402520c9ac7023bbb",
      "line": 240,
      "relation": "increases",
      "source": 125,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that individuals who have suffered severe hypoxia or ischemia are more susceptible to developing AD [63].",
      "key": "c7a762306f13e7a1068bfaedb88ce271",
      "line": 377,
      "relation": "increases",
      "source": 125,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "b0b3323a9ff27b47841448bf11f4925a",
      "line": 388,
      "relation": "increases",
      "source": 125,
      "target": 70
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "20b2dd906cc026b52283eaeb72ca9d2c",
      "line": 389,
      "relation": "increases",
      "source": 125,
      "target": 47
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "ba45c4b957857850994aa9c860d4ec36",
      "line": 392,
      "relation": "increases",
      "source": 125,
      "target": 12
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "7717f9642e49c6ff50a231eee2bd0ab1",
      "line": 393,
      "relation": "increases",
      "source": 125,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hypoxia and DFO, both are known to upregulate HIF-1, can increase TH expression in rat brains [84–85].",
      "key": "bdd3b4f6db3a03ee9e3af64569b3f500",
      "line": 451,
      "relation": "increases",
      "source": 125,
      "target": 137
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "5f87565c85a318e326ad2b3b740c9576",
      "line": 241,
      "relation": "increases",
      "source": 38,
      "target": 118
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "f4831ee2eef0d0bde1da8edb98e2c863",
      "line": 256,
      "relation": "negativeCorrelation",
      "source": 118,
      "target": 106,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "cf19c7cb8e30eb36e5f54bdb759be945",
      "line": 271,
      "relation": "negativeCorrelation",
      "source": 118,
      "target": 113,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Cerebrospinal Fluid",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that EPO levels are significantly decreased in cerebrospinal fluids from patients with differing severity and duration of ALS [46], while EPO immunoreacitivity is significantly increased in midbrain, brain stem, and cortex of the SOD1G93A mutant mice [47].",
      "key": "c95bd7fdf904dc6057a3e895d69833ed",
      "line": 300,
      "relation": "decreases",
      "source": 118,
      "target": 78
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF can induce angiogenesis and increase blood supply to motor neurons during hypoxia through action on endothelial cells [39].",
      "key": "8165ecd5a9171e2d2b47be0456c7c3fc",
      "line": 249,
      "relation": "increases",
      "source": 106,
      "target": 27
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Spinal Cord",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "By this mechanism, VEGF can prevent the death of motor neurons and postpone the occurrence of ALS.",
      "key": "f7b2e074e31f4e3b3b9593bca3717493",
      "line": 280,
      "relation": "increases",
      "source": 106,
      "target": 27
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "6de1759eb2ef1f3aa6a239f0128629a6",
      "line": 255,
      "relation": "negativeCorrelation",
      "source": 106,
      "target": 124
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "14b6bd001d889ceacca95ad457a75be0",
      "line": 256,
      "relation": "negativeCorrelation",
      "source": 106,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Spinal Cord",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "By this mechanism, VEGF can prevent the death of motor neurons and postpone the occurrence of ALS.",
      "key": "b70106b37a8292007159e8104dfacfb4",
      "line": 281,
      "relation": "decreases",
      "source": 106,
      "target": 118
    },
    {
      "key": "537473d948e6f98c9b563d2c450c8ce4",
      "relation": "partOf",
      "source": 106,
      "target": 53
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "dopaminergic neuron",
            "namespace": "Cell"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In an embryonic rat explant model, DAergic neurons, particularly, exhibit increased survival in response to VEGF application [92], suggesting that VEGF may promote the growth of DAergic neurons.",
      "key": "255f0d2b09099176bf8a09472c570cb0",
      "line": 531,
      "relation": "increases",
      "source": 106,
      "target": 19
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, a mouse model of pan-neuronal overexpression of VEGF demonstrates that VEGF provides protection against MPTP toxicity in nigral cells [88].",
      "key": "2415197e173f3b4a1ca2098423ee722f",
      "line": 538,
      "relation": "decreases",
      "source": 106,
      "target": 28
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "e636360a2ceac1a602bf82e3a0f4e130",
      "line": 255,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 106
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "72d308a5cea29e89647d9a5c7e7a533d",
      "line": 272,
      "relation": "decreases",
      "source": 64,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "08ad6085c3fbf8b1d3352385f1289c9d",
      "line": 273,
      "relation": "decreases",
      "source": 64,
      "target": 129
    },
    {
      "key": "47807a4dabf733f508ee5c3d12f9cb52",
      "relation": "partOf",
      "source": 104,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brainstem",
            "namespace": "Anatomy"
          },
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          },
          {
            "identifier": "midbrain",
            "namespace": "Anatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that EPO levels are significantly decreased in cerebrospinal fluids from patients with differing severity and duration of ALS [46], while EPO immunoreacitivity is significantly increased in midbrain, brain stem, and cortex of the SOD1G93A mutant mice [47].",
      "key": "c34cb719ab5488db358f7148f6653aba",
      "line": 304,
      "relation": "increases",
      "source": 104,
      "target": 78
    },
    {
      "key": "fb50aa351fa3da48a87d15c07b9ac097",
      "relation": "partOf",
      "source": 104,
      "target": 62
    },
    {
      "key": "665207989464c6cc55a6487f9862362a",
      "relation": "partOf",
      "source": 104,
      "target": 61
    },
    {
      "key": "e1d27e6f900a66a1e674ad25592095d0",
      "relation": "hasVariant",
      "source": 103,
      "target": 104
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "bea225ef3b20a7b37b607a1f933f5003",
      "line": 290,
      "relation": "decreases",
      "source": 53,
      "target": 28
    },
    {
      "key": "5fa609c4f84f8dd81769b5f66dc170de",
      "relation": "partOf",
      "source": 99,
      "target": 53
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "59849f58a3b044a57a13c42dfe4dbffc",
      "line": 291,
      "relation": "association",
      "source": 99,
      "target": 26
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Motor Neurons",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "3d6bfafa664d4a594825bf5f5b249668",
      "line": 291,
      "relation": "association",
      "source": 26,
      "target": 99
    },
    {
      "key": "7fa8bacfbc779a6c08e5ca90c4f3e6a8",
      "relation": "partOf",
      "source": 78,
      "target": 62
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "dddb59fe606704e6d212d5eec0efc090",
      "line": 424,
      "relation": "decreases",
      "source": 78,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "d3038744780729045ffc9619f77496a6",
      "line": 425,
      "relation": "decreases",
      "source": 78,
      "target": 17,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "MN9D",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "EPO is neuroprotective against the DAergic neurotoxin, 6- hydroxydopamine, in both the DAergic cell line MN9D and primary DAergic neurons [91].",
      "key": "4b45690539c7ccd557c9c69ffd6a5e5c",
      "line": 523,
      "relation": "decreases",
      "source": 78,
      "target": 16
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "89cfe781e1d544e7018257c8a832bf63",
      "line": 311,
      "relation": "decreases",
      "source": 62,
      "target": 118
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "07eb36fe9c4f73d7f4e4ca8c4ed02707",
      "line": 312,
      "relation": "decreases",
      "source": 62,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "44f677b04ad1bcd95c881cc936b5bdae",
      "line": 313,
      "relation": "decreases",
      "source": 62,
      "target": 36
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "b0ff3d0c6a2bbce19a1c26a7d7e3e528",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 25,
      "target": 111
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "9dfeea6e06486a63e63bd11ff857545c",
      "line": 321,
      "relation": "decreases",
      "source": 25,
      "target": 37
    },
    {
      "key": "52b2a36b626bebd4e6c92f0407e83a80",
      "relation": "partOf",
      "source": 25,
      "target": 61
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "93d7678ecce7da293003b12e8999d1eb",
      "line": 332,
      "relation": "increases",
      "source": 25,
      "target": 134
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "10cc42cef033147d525fc83398c80f45",
      "line": 333,
      "relation": "increases",
      "source": 25,
      "target": 133
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "0caa67f9dc1b1385b1ec4f9d1d516542",
      "line": 334,
      "relation": "increases",
      "source": 25,
      "target": 138
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that M30 simultaneously attenuates tau phosphorylation and protects cortical neurons against Aβ (25– 35) toxicity [57].",
      "key": "7ed52d7f6932fbb2a547b35d07454fc3",
      "line": 339,
      "relation": "decreases",
      "source": 25,
      "target": 97
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that M30 simultaneously attenuates tau phosphorylation and protects cortical neurons against Aβ (25– 35) toxicity [57].",
      "key": "9cb1d991862c2364aa9f109486bd68b1",
      "line": 341,
      "relation": "decreases",
      "source": 25,
      "target": 127
    },
    {
      "key": "335d51bc28c8a473ecadc56aaf1d5896",
      "relation": "partOf",
      "source": 25,
      "target": 60
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "b9c1c5e6cbfd50ac5832a1ab3ef0f79b",
      "line": 641,
      "relation": "increases",
      "source": 25,
      "target": 76
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "ab110246340b3632e336d1e914bc0eae",
      "line": 643,
      "relation": "increases",
      "source": 25,
      "target": 106
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "63fef4573f3a4b223ea7ab29960db9eb",
      "line": 645,
      "relation": "increases",
      "source": 25,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Amyotrophic Lateral Sclerosis",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "02d82a314a9aab2b78ab47b9b017c2c9",
      "line": 323,
      "relation": "decreases",
      "source": 61,
      "target": 118
    },
    {
      "key": "080972dc80c9f38e1b7d1f7bc3b27b25",
      "relation": "hasVariant",
      "source": 96,
      "target": 97
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "1d9dc6d9baa9b38832929ca16d09f2ba",
      "line": 356,
      "relation": "increases",
      "source": 22,
      "target": 111
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "C6 cell",
            "namespace": "CellLine"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Preconditioning of C6 astroglial cells with DFO can activate HIF-1 and thereby attenuate cytotoxicity induced by mitochondrial inhibitor 3-nitropropionic acid [102].",
      "key": "dc177beb371fea2e996cacbae8b995bf",
      "line": 617,
      "relation": "increases",
      "source": 22,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "811f135c7e026e0aa50a12770d89816d",
      "line": 357,
      "relation": "decreases",
      "source": 22,
      "target": 42
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "d787c386860629e399c6c873eb9815a1",
      "line": 358,
      "relation": "decreases",
      "source": 22,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hypoxia and DFO, both are known to upregulate HIF-1, can increase TH expression in rat brains [84–85].",
      "key": "b2293fea7473dab898e4100611acad5c",
      "line": 452,
      "relation": "increases",
      "source": 22,
      "target": 137
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, DFO is shown to prevent neurotoxicity in the MPTP-mouse model of PD [89].",
      "key": "21ec4bc2fe116ae14576fe4d2c98e859",
      "line": 507,
      "relation": "decreases",
      "source": 22,
      "target": 130
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Ventricles",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, Ben-Shachar et al. have demonstrated that intracerebroventricular-injection of DFO protects the rat brain from DAergic neurodegeneration induced by 6-hydroxydopamine [90].",
      "key": "509352a7c35e2a55929be458dac33bb1",
      "line": 516,
      "relation": "decreases",
      "source": 22,
      "target": 119
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "4f99630e808895af47f3e27dcfc2fc79",
      "line": 571,
      "relation": "negativeCorrelation",
      "source": 22,
      "target": 132
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "C6 cell",
            "namespace": "CellLine"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Preconditioning of C6 astroglial cells with DFO can activate HIF-1 and thereby attenuate cytotoxicity induced by mitochondrial inhibitor 3-nitropropionic acid [102].",
      "key": "aeb9b59e9e3c992d85ae0fde0c6173a3",
      "line": 618,
      "relation": "decreases",
      "source": 22,
      "target": 132
    },
    {
      "key": "af5dd96c7a33cfcaf8e1d1f6b11fe38c",
      "relation": "partOf",
      "source": 22,
      "target": 57
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "50dc2f3703c6e0d3c1fd8b5e69963be4",
      "line": 370,
      "relation": "decreases",
      "source": 116,
      "target": 46
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "6eee628c05968a4907d4b180e80283e5",
      "line": 371,
      "relation": "negativeCorrelation",
      "source": 116,
      "target": 34
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "2bde8f9cf51709d3f887395adf90c200",
      "line": 372,
      "relation": "negativeCorrelation",
      "source": 116,
      "target": 33
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "b3c2e5a0fc65b1a688cafc09ec4a7b18",
      "line": 373,
      "relation": "increases",
      "source": 116,
      "target": 45
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "a71b9be246a216483cb893d087382cdf",
      "line": 408,
      "relation": "decreases",
      "source": 116,
      "target": 135
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "61800c4fd48929a06efac515990c0ebe",
      "line": 409,
      "relation": "decreases",
      "source": 116,
      "target": 136
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "efe1801b1871ba9703177e8cb9af8b9e",
      "line": 371,
      "relation": "negativeCorrelation",
      "source": 34,
      "target": 116
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "7307b3399438f83d75ce839c880e2470",
      "line": 372,
      "relation": "negativeCorrelation",
      "source": 33,
      "target": 116
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that individuals who have suffered severe hypoxia or ischemia are more susceptible to developing AD [63].",
      "key": "39ce2143ded5100f8137ec6983864c16",
      "line": 378,
      "relation": "increases",
      "source": 121,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "747d4eb080b471ad0c4ad6c52f76277c",
      "line": 390,
      "relation": "increases",
      "source": 47,
      "target": 12
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "b0e61c91ba28b9c1bbe298b44bffa9d7",
      "line": 391,
      "relation": "increases",
      "source": 47,
      "target": 17
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "6dd2a64a74c14212ea4ca35f7fb5eb7b",
      "line": 423,
      "relation": "increases",
      "source": 17,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "872d0b5091d5584032b70bc8944c9169",
      "line": 410,
      "relation": "regulates",
      "source": 101,
      "target": 33
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Alzheimer Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "b9d223641def202dd590c66b1af20a77",
      "line": 411,
      "relation": "regulates",
      "source": 102,
      "target": 33
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "PC12",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          },
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "a3b806f90764c50b1ba51c7e9e98aeaa",
      "line": 437,
      "relation": "decreases",
      "source": 0,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "5a23ab8deda8b68efaa9654cd9048a46",
      "line": 499,
      "relation": "increases",
      "source": 0,
      "target": 28
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, DFO is shown to prevent neurotoxicity in the MPTP-mouse model of PD [89].",
      "key": "94b3f0075a268419647e255f7e7eeef7",
      "line": 506,
      "relation": "increases",
      "source": 0,
      "target": 130
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "PC12",
            "namespace": "CellLine"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          },
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "85003233cd7e188c8749d9c2c9e969ef",
      "line": 438,
      "relation": "negativeCorrelation",
      "source": 117,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Neostriatum",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Injection of the PHD inhibitor FG0041 increases HIF-1 activity and the extracellular DA level in the striatum of the rat brain [87].",
      "key": "c4e9132901aa307d284a665b86ec5acd",
      "line": 468,
      "relation": "increases",
      "source": 21,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Neostriatum",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Injection of the PHD inhibitor FG0041 increases HIF-1 activity and the extracellular DA level in the striatum of the rat brain [87].",
      "key": "0dba481a4caedb27b9da07c23246c17c",
      "line": 469,
      "relation": "increases",
      "source": 21,
      "target": 14,
      "target_modifier": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      }
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, administration of HIF-1 activator cobalt chloride raises the DA release [87].",
      "key": "f71aba66bf952d146d044a1b1f17c505",
      "line": 475,
      "relation": "increases",
      "source": 4,
      "target": 14,
      "target_modifier": {
        "effect": {
          "fromLoc": {
            "identifier": "0005622",
            "name": "intracellular",
            "namespace": "go"
          },
          "toLoc": {
            "identifier": "0005615",
            "name": "extracellular space",
            "namespace": "go"
          }
        },
        "modifier": "Translocation"
      }
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, administration of HIF-1 activator cobalt chloride raises the DA release [87].",
      "key": "c71d4630bdc6650214ccaa014e3bcbe9",
      "line": 476,
      "relation": "increases",
      "source": 4,
      "target": 111
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "db3a805956d7b3bf953c5ab54e754040",
      "line": 569,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 132
    },
    {
      "annotations": {
        "CellLine": [
          {
            "identifier": "C6 cell",
            "namespace": "CellLine"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, the preconditioning of rat C6 astroglia cells with the CoCl2 provides extensive cytoprotective effects against metabolic insults induced by mitochondrial toxin 3-nitropropionic acid [102].",
      "key": "8ccd1c0e4a789aa8b5fe9ba3dfd9f409",
      "line": 600,
      "relation": "increases",
      "source": 4,
      "target": 131
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "c078fe90c9df9b2badf37698f121ce23",
      "line": 489,
      "relation": "increases",
      "source": 2,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "0922f10832d96612d995008beb6db956",
      "line": 490,
      "relation": "increases",
      "source": 2,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "32315dea85dcb44e47ecb418c2a9dd15",
      "line": 491,
      "relation": "increases",
      "source": 2,
      "target": 65
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, 3,4-DHB also elevates the expression of HIF-dependent genes such as heme oxygenase-1 and manganese superoxide dismutase in the presence of MPTP [88].",
      "key": "9cab3fed8f09684701b8f68839c70b6e",
      "line": 654,
      "relation": "increases",
      "source": 2,
      "target": 67
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "d4ff77029e308d5da269da1af07884fb",
      "line": 497,
      "relation": "increases",
      "source": 8,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Substantia Nigra",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "bc7a9453c0fd1ccd9c7375eeb7386b26",
      "line": 500,
      "relation": "decreases",
      "source": 8,
      "target": 28
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Another metal chelator, clioquinol, increases HIF-1α expression and reduces cell death and mutant protein accumulation in both a tissue culture model and a transgenic Huntington’s animal model [101–102].",
      "key": "da5fe57c2e7ee54d56baced654ae85be",
      "line": 578,
      "relation": "decreases",
      "source": 8,
      "target": 18
    },
    {
      "annotations": {
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Clioquinol-treated transgenic HD mice (R6/2) demonstrate improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation as well as enhanced motor functions and survival [101].",
      "key": "b0fac2daf3e8087e7e86817b0968cc46",
      "line": 626,
      "relation": "decreases",
      "source": 8,
      "target": 126
    },
    {
      "annotations": {
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Clioquinol-treated transgenic HD mice (R6/2) demonstrate improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation as well as enhanced motor functions and survival [101].",
      "key": "32152897c9b803b65448ed2a8eb884b0",
      "line": 627,
      "relation": "increases",
      "source": 8,
      "target": 123
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Cerebral Ventricles",
            "namespace": "MeSHAnatomy"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Parkinson Disease",
            "namespace": "MeSHDisease"
          }
        ],
        "Species": [
          {
            "identifier": "10116",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, Ben-Shachar et al. have demonstrated that intracerebroventricular-injection of DFO protects the rat brain from DAergic neurodegeneration induced by 6-hydroxydopamine [90].",
      "key": "bcd0c6db1c5424a85de478cfd689a7d0",
      "line": 515,
      "relation": "increases",
      "source": 16,
      "target": 119
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this way, huntingtin protein-induced mitochondrial metabolism dysfunction in the brain serves as the primary cause of HD pathogenesis.",
      "key": "d81f7ddf1b25406a46a1f143631bfaa2",
      "line": 548,
      "relation": "negativeCorrelation",
      "source": 95,
      "target": 128
    },
    {
      "key": "0ce6657d55cebf519ec5f8609a572687",
      "relation": "hasVariant",
      "source": 94,
      "target": 95
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Huntington Disease",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this way, huntingtin protein-induced mitochondrial metabolism dysfunction in the brain serves as the primary cause of HD pathogenesis.",
      "key": "f60eb66da223b9d2c7c8e33a8abbbfa5",
      "line": 548,
      "relation": "negativeCorrelation",
      "source": 128,
      "target": 95
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "4cc1d7ea575e4f422bdeab7e05ac7b24",
      "line": 569,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 4
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "569826d87503cbe117c438f7b16e9af6",
      "line": 570,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 10
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "195ae5438167ef8330f2264b58a90e61",
      "line": 571,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 22
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "1eb814045b4f2bf792a59f466c78099f",
      "line": 570,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 132
    },
    {
      "annotations": {
        "MeSHDisease": [
          {
            "identifier": "Glioma",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "68460fc9657d5b568e309d52b9051495",
      "line": 572,
      "relation": "increases",
      "source": 3,
      "target": 132
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "3887da75d388098c4c45d954fce3bc6f",
      "line": 590,
      "relation": "increases",
      "source": 112,
      "target": 80,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "6583fae439ea9d38a2d8dec0e09b6f78",
      "line": 592,
      "relation": "increases",
      "source": 112,
      "target": 119
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "6e89a131df42dae929fe57bd1efebdca",
      "line": 591,
      "relation": "decreases",
      "source": 69,
      "target": 80,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "4dccba1dcd554b813d934e1401a9ee50",
      "line": 593,
      "relation": "increases",
      "source": 69,
      "target": 119
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Iron chelators have been traditionally regarded to provide neuroprotection by sequestering redox-active iron and thereby prevent hydroxyl radical formation [106].",
      "key": "7a4e976b5b7aae40e782d3aa599b2987",
      "line": 606,
      "relation": "decreases",
      "source": 56,
      "target": 15
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The sequestering of ferrous ion by DFO prevents formation of a catalytically active center in the PHDs and induces HIF-1 activation [11].",
      "key": "ac7effd054d0fd7537747b7eab6cd307",
      "line": 611,
      "relation": "increases",
      "source": 57,
      "target": 111,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "M30 and another iron chelator HLA20 (Fig. 1.4) are both designed from the brain-permeable iron chelator VK28 (Fig. 1.5) and chemically attached to the neuroprotective N-propargyl moiety of the anti-Parkinson drug rasageline.",
      "key": "4767573591f6497d8e940f44ae94b5bc",
      "line": 634,
      "relation": "decreases",
      "source": 60,
      "target": 117
    },
    {
      "key": "27e3dbafaf9f9b07ece31edfe5720a15",
      "relation": "partOf",
      "source": 23,
      "target": 60
    },
    {
      "key": "584312a2e9c2d54a5e3f8c2f55ca05c8",
      "relation": "partOf",
      "source": 23,
      "target": 59
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "M30 and another iron chelator HLA20 (Fig. 1.4) are both designed from the brain-permeable iron chelator VK28 (Fig. 1.5) and chemically attached to the neuroprotective N-propargyl moiety of the anti-Parkinson drug rasageline.",
      "key": "a7086137850d62bbda5ef4a51abbcfba",
      "line": 635,
      "relation": "decreases",
      "source": 59,
      "target": 117
    },
    {
      "key": "9a94b6286bf953f1947d084ad804fcfd",
      "relation": "partOf",
      "source": 24,
      "target": 59
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "51bcbd389a6c3317d59d12e4baa42876",
      "line": 642,
      "relation": "increases",
      "source": 24,
      "target": 76
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "5e86876a088808e23af4492ce3749931",
      "line": 644,
      "relation": "increases",
      "source": 24,
      "target": 106
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "first": "Zhang Z",
        "identifier": "21861815",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "namespace": "pubmed",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "105fc70266bdf813c151e41776e9d53e",
      "line": 646,
      "relation": "increases",
      "source": 24,
      "target": 71
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\")",
      "concept": {
        "name": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "429d8cf3b81b74b8cc50a6d837424a61"
    },
    {
      "bel": "a(CHEBI:\"2-oxoglutarate(1-)\")",
      "concept": {
        "name": "2-oxoglutarate(1-)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "de54d713839cc6a58835a52125bf81db"
    },
    {
      "bel": "a(CHEBI:\"3,4-dihydroxybenzoate\")",
      "concept": {
        "name": "3,4-dihydroxybenzoate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ec230da79dfc68723e0b7fcfa09946d3"
    },
    {
      "bel": "a(CHEBI:\"3-nitropropanoic acid\")",
      "concept": {
        "name": "3-nitropropanoic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "eb92df215e7b704aeb702301bcef9d67"
    },
    {
      "bel": "a(CHEBI:\"cobalt dichloride\")",
      "concept": {
        "name": "cobalt dichloride",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a8851a41593d338d63bf1fbf24f84c53"
    },
    {
      "bel": "a(CHEBI:\"hydrogen peroxide\")",
      "concept": {
        "name": "hydrogen peroxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2a33dd72d09a3b66f80326bcf6e3bfd6"
    },
    {
      "bel": "a(CHEBI:\"iron chelator\")",
      "concept": {
        "name": "iron chelator",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "6b62ab97bce3a64c53b321a3fcb3c2f8"
    },
    {
      "bel": "a(CHEBI:\"iron(2+)\")",
      "concept": {
        "name": "iron(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "be7ed197cc239803fafad58c7dc415ba"
    },
    {
      "bel": "a(CHEBI:5-chloro-7-iodoquinolin-8-ol)",
      "concept": {
        "name": "5-chloro-7-iodoquinolin-8-ol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "0365360fe7f9614d3673b5933d775719"
    },
    {
      "bel": "a(CHEBI:ATP)",
      "concept": {
        "name": "ATP",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "08c2bd47cf55782389bbaba34887a39c"
    },
    {
      "bel": "a(CHEBI:L-mimosine)",
      "concept": {
        "name": "L-mimosine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "946a35fd26738827f5c416663944238c"
    },
    {
      "bel": "a(CHEBI:NADPH)",
      "concept": {
        "name": "NADPH",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "20e6cc8f83eabc7a776ebf34466f49da"
    },
    {
      "bel": "a(CHEBI:amyloid-beta)",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1bc8499994bfdd953f21795fb20a70bc"
    },
    {
      "bel": "a(CHEBI:dioxygen)",
      "concept": {
        "name": "dioxygen",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "bbe161dd595b582241898258462de427"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:hydroxyl)",
      "concept": {
        "name": "hydroxyl",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "085e62ac8ad7bca76ee6367f02410631"
    },
    {
      "bel": "a(CHEBI:oxidopamine)",
      "concept": {
        "name": "oxidopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8a3aa6c226d61ff2f130381a1636366f"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "ddfb3dfcec37bcf8a1201a85c5723c38"
    },
    {
      "bel": "a(MESH:\"Dopaminergic Neurons\")",
      "concept": {
        "name": "Dopaminergic Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "47bd22a33070cbf256cd62473e57ed0b"
    },
    {
      "bel": "a(NCIT:C13737)",
      "concept": {
        "name": "C13737",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "703c8c347fa9a77846755cbb29c29275"
    },
    {
      "bel": "a(PUBCHEM:137275695)",
      "concept": {
        "name": "137275695",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "4fbd878fe0190fdb3c6f5d5aacc86d1f"
    },
    {
      "bel": "a(PUBCHEM:2973)",
      "concept": {
        "name": "2973",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "667de31ab8c2cd640c339162ce163b06"
    },
    {
      "bel": "a(PUBCHEM:3052776)",
      "concept": {
        "name": "3052776",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "76618d48d72b37702e81e5699fca608a"
    },
    {
      "bel": "a(PUBCHEM:6918819)",
      "concept": {
        "name": "6918819",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "2620d8c98924d93e522701a298bd05b8"
    },
    {
      "bel": "a(PUBCHEM:6918822)",
      "concept": {
        "name": "6918822",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "9ba59056bd19c74213cb3567956dd85b"
    },
    {
      "bel": "bp(GO:\"axon guidance\")",
      "concept": {
        "name": "axon guidance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5e1e928fbee57451c4342b253ca64a03"
    },
    {
      "bel": "bp(GO:\"blood vessel development\")",
      "concept": {
        "name": "blood vessel development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c687ec7b1e72a3254276f98626f2c786"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"cell redox homeostasis\")",
      "concept": {
        "name": "cell redox homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8e747e89cd7da5dcbc9c2cadff662c4"
    },
    {
      "bel": "bp(GO:\"cellular response to oxidative stress\")",
      "concept": {
        "name": "cellular response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "97bc042e019a8c4bc942ab08644c5f86"
    },
    {
      "bel": "bp(GO:\"cellular response to oxygen-glucose deprivation\")",
      "concept": {
        "name": "cellular response to oxygen-glucose deprivation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2ac11bb46c68dee2589a9f3c01622500"
    },
    {
      "bel": "bp(GO:\"energy homeostasis\")",
      "concept": {
        "name": "energy homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d350b37fb24c6e9ace1f29d8faf883ea"
    },
    {
      "bel": "bp(GO:\"glucose import\")",
      "concept": {
        "name": "glucose import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f57bac670efe08d9a46dfe9b4e490b74"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "concept": {
        "name": "glucose metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "57837c8bd480cd6e4257602591b12dac"
    },
    {
      "bel": "bp(GO:\"glycolytic process\")",
      "concept": {
        "name": "glycolytic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "de85d9d53df85cf1d871ae538e4286b3"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"neuron death in response to oxidative stress\")",
      "concept": {
        "name": "neuron death in response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a56452128add0e25ccff634b67eb42ce"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"pentose-phosphate shunt\")",
      "concept": {
        "name": "pentose-phosphate shunt",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "44f00ff8fb0b1922f4c83c65afbb1a13"
    },
    {
      "bel": "bp(GO:\"response to hypoxia\")",
      "concept": {
        "name": "response to hypoxia",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8c5505b03e1e564975e18380c4d05f0c"
    },
    {
      "bel": "bp(GO:angiogenesis)",
      "concept": {
        "name": "angiogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d6fd378871feec80135a583c419e7f1"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(NCIT:C16407)",
      "concept": {
        "name": "C16407",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "a354f6f9fd43df07a23e5ea709988efb"
    },
    {
      "bel": "bp(NCIT:C16559)",
      "concept": {
        "name": "C16559",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "28aaf8757d534e110927a237d5602ccb"
    },
    {
      "bel": "bp(NCIT:C17741)",
      "concept": {
        "name": "C17741",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "bd9579b6c4a167581395e09818647e73"
    },
    {
      "bel": "bp(NCIT:C94869)",
      "concept": {
        "name": "C94869",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "8f756a3ae4fb744e5d3d89cb2988c49b"
    },
    {
      "bel": "complex(GO:\"gamma-secretase complex\")",
      "concept": {
        "name": "gamma-secretase complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "cb9f772c242dc7192de1b4f6180ecaa5"
    },
    {
      "bel": "complex(a(NCIT:C13737), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "ad563e6d7c5232b981ec6845d644df62",
      "members": [
        {
          "bel": "a(NCIT:C13737)",
          "concept": {
            "name": "C13737",
            "namespace": "NCIT"
          },
          "function": "Abundance",
          "id": "703c8c347fa9a77846755cbb29c29275"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:ARNT), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "05e2f768d03ef28a3dc82c50e4dab4e5",
      "members": [
        {
          "bel": "p(HGNC:ARNT)",
          "concept": {
            "name": "ARNT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "56ea0628bda070becb2f1f805e31ff2f"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CREBBP), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "30d5e97143b7d691f58542011d96b85d",
      "members": [
        {
          "bel": "p(HGNC:CREBBP)",
          "concept": {
            "name": "CREBBP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46148e81658994544d74b5db695e5cd8"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:EP300), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "55865d469c6bf1e40ce3175a63dba729",
      "members": [
        {
          "bel": "p(HGNC:EP300)",
          "concept": {
            "name": "EP300",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e20d8e85f8a2efec4b3796446b8aa684"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HIF1A), p(HGNC:VHL))",
      "function": "Complex",
      "id": "d631d4374e98b4ff97ee5decc61c8a5f",
      "members": [
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        },
        {
          "bel": "p(HGNC:VHL)",
          "concept": {
            "name": "VHL",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "51ee7ec3981d10efa166f95b9b4fc8d0"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:NRP1), p(HGNC:VEGFA))",
      "function": "Complex",
      "id": "745be4a09f6cb7c6e38af59c00f894be",
      "members": [
        {
          "bel": "p(HGNC:NRP1)",
          "concept": {
            "name": "NRP1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "281ebbfe33238809d916d5f4b5d90d98"
        },
        {
          "bel": "p(HGNC:VEGFA)",
          "concept": {
            "name": "VEGFA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3537912f85b0c685b323cfa4aaff98c1"
        }
      ]
    },
    {
      "bel": "complex(p(MESH:\"Hypoxia-Inducible Factor 1\"), p(NCIT:C13718))",
      "function": "Complex",
      "id": "8b39a302493673aa4d5ba9b637bd92a4",
      "members": [
        {
          "bel": "p(MESH:\"Hypoxia-Inducible Factor 1\")",
          "concept": {
            "name": "Hypoxia-Inducible Factor 1",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "4e348c44a211012bbb3e2f65fe3081ba"
        },
        {
          "bel": "p(NCIT:C13718)",
          "concept": {
            "name": "C13718",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "543bd74118561c4ee9d67403c9b8256a"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"2-oxoglutarate(1-)\"), a(CHEBI:\"iron(2+)\"), a(CHEBI:dioxygen))",
      "function": "Composite",
      "id": "8ce01a14c56e9328bc20932bb16a54d1",
      "members": [
        {
          "bel": "a(CHEBI:\"2-oxoglutarate(1-)\")",
          "concept": {
            "name": "2-oxoglutarate(1-)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "de54d713839cc6a58835a52125bf81db"
        },
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        },
        {
          "bel": "a(CHEBI:dioxygen)",
          "concept": {
            "name": "dioxygen",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "bbe161dd595b582241898258462de427"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"iron chelator\"), a(CHEBI:\"iron(2+)\"))",
      "function": "Composite",
      "id": "620337bf20b9ce982bb603e71c5b6e7a",
      "members": [
        {
          "bel": "a(CHEBI:\"iron chelator\")",
          "concept": {
            "name": "iron chelator",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "6b62ab97bce3a64c53b321a3fcb3c2f8"
        },
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"iron(2+)\"), a(PUBCHEM:2973))",
      "function": "Composite",
      "id": "36d4ad5d691aef51c622a40d04666ed7",
      "members": [
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        },
        {
          "bel": "a(PUBCHEM:2973)",
          "concept": {
            "name": "2973",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "667de31ab8c2cd640c339162ce163b06"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:dioxygen), p(HGNC:HIF1AN))",
      "function": "Composite",
      "id": "147e53292ce5c10558c6194fc8f9508b",
      "members": [
        {
          "bel": "a(CHEBI:dioxygen)",
          "concept": {
            "name": "dioxygen",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "bbe161dd595b582241898258462de427"
        },
        {
          "bel": "p(HGNC:HIF1AN)",
          "concept": {
            "name": "HIF1AN",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6d8d1becde78925aa097d4902e95ac7a"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:3052776), a(PUBCHEM:6918819))",
      "function": "Composite",
      "id": "4efa208a72bb83812f2523118e3e22d6",
      "members": [
        {
          "bel": "a(PUBCHEM:3052776)",
          "concept": {
            "name": "3052776",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "76618d48d72b37702e81e5699fca608a"
        },
        {
          "bel": "a(PUBCHEM:6918819)",
          "concept": {
            "name": "6918819",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "2620d8c98924d93e522701a298bd05b8"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:3052776), a(PUBCHEM:6918822))",
      "function": "Composite",
      "id": "709d01fd0504168f9524454121aab68b",
      "members": [
        {
          "bel": "a(PUBCHEM:3052776)",
          "concept": {
            "name": "3052776",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "76618d48d72b37702e81e5699fca608a"
        },
        {
          "bel": "a(PUBCHEM:6918822)",
          "concept": {
            "name": "6918822",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "9ba59056bd19c74213cb3567956dd85b"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:6918822), p(HGNC:SOD1, var(\"Gly93Ala\")))",
      "function": "Composite",
      "id": "f89604a8504c0450465c7ff8bec25214",
      "members": [
        {
          "bel": "a(PUBCHEM:6918822)",
          "concept": {
            "name": "6918822",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "9ba59056bd19c74213cb3567956dd85b"
        },
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:EPO), p(HGNC:SOD1, var(\"Gly93Ala\")))",
      "function": "Composite",
      "id": "f965f0fd0ddd767ecab3212698b64f84",
      "members": [
        {
          "bel": "p(HGNC:EPO)",
          "concept": {
            "name": "EPO",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "25000a2f97feb5507a44691b0fd5a366"
        },
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:HIF1A, pmod(go:0016567 ! \"protein ubiquitination\")), p(NCIT:C13970))",
      "function": "Composite",
      "id": "94a06ded07665e5711d10d631da51353",
      "members": [
        {
          "bel": "p(HGNC:HIF1A, pmod(go:0016567 ! \"protein ubiquitination\"))",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "75276a2690a68e3ed9d0dce4bf757a86",
          "variants": [
            {
              "concept": {
                "identifier": "0016567",
                "name": "protein ubiquitination",
                "namespace": "go"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(NCIT:C13970)",
          "concept": {
            "name": "C13970",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "5d2ad7617b22c9e31ec98493d0d94588"
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:SOD1, var(\"Gly93Ala\")), p(NCIT:C13718))",
      "function": "Composite",
      "id": "9c9d72102df8df1cd0fe89606996c89f",
      "members": [
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        },
        {
          "bel": "p(NCIT:C13718)",
          "concept": {
            "name": "C13718",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "543bd74118561c4ee9d67403c9b8256a"
        }
      ]
    },
    {
      "bel": "g(HGNC:HMOX1)",
      "concept": {
        "name": "HMOX1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "d8c8fde724f6e9b21d709b9bd79ec563"
    },
    {
      "bel": "g(HGNC:SLC40A1)",
      "concept": {
        "name": "SLC40A1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "c4490067606c982ff6657037aff39796"
    },
    {
      "bel": "g(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "30c6a726629f949afcafd8cebbd3ff37"
    },
    {
      "bel": "p(HGNC:ARNT)",
      "concept": {
        "name": "ARNT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "56ea0628bda070becb2f1f805e31ff2f"
    },
    {
      "bel": "p(HGNC:ASPH)",
      "concept": {
        "name": "ASPH",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0873dbcbd4589d81f34ad4c709d1b9b"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:CREBBP)",
      "concept": {
        "name": "CREBBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "46148e81658994544d74b5db695e5cd8"
    },
    {
      "bel": "p(HGNC:EGLN1)",
      "concept": {
        "name": "EGLN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c4717bf543c3a7038331f50cbc3bc673"
    },
    {
      "bel": "p(HGNC:EGLN2)",
      "concept": {
        "name": "EGLN2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "53659ecdbb07cf0542e2fb5579dea84d"
    },
    {
      "bel": "p(HGNC:EGLN3)",
      "concept": {
        "name": "EGLN3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b626b92928b114201a4cafad356c75e3"
    },
    {
      "bel": "p(HGNC:ENO1)",
      "concept": {
        "name": "ENO1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a6b29776b451be82b0b36b69cd1dd5a7"
    },
    {
      "bel": "p(HGNC:EP300)",
      "concept": {
        "name": "EP300",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e20d8e85f8a2efec4b3796446b8aa684"
    },
    {
      "bel": "p(HGNC:EPO)",
      "concept": {
        "name": "EPO",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "25000a2f97feb5507a44691b0fd5a366"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:HIF1A)",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(NCIT:C16944))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bbcb41baaec72f06b62008642ac399d2",
      "variants": [
        {
          "concept": {
            "name": "C16944",
            "namespace": "NCIT"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b61ee2a7785016745b4ce9eaf97d5e72",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0006468 ! \"protein phosphorylation\", Thr, 796))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "01e48a8b9a4fa92b08e2ee3758b55342",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 796
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0006473 ! \"protein acetylation\", Lys, 532))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "11efd35b324d1b510632a73a67296e01",
      "variants": [
        {
          "code": "Lys",
          "concept": {
            "identifier": "0006473",
            "name": "protein acetylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 532
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0016567 ! \"protein ubiquitination\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "75276a2690a68e3ed9d0dce4bf757a86",
      "variants": [
        {
          "concept": {
            "identifier": "0016567",
            "name": "protein ubiquitination",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0016925 ! \"protein sumoylation\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "452423b36d629a10483446a09303951c",
      "variants": [
        {
          "concept": {
            "identifier": "0016925",
            "name": "protein sumoylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0017014 ! \"protein nitrosylation\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "35d92edcaa4411f2bedd4b312d18cf99",
      "variants": [
        {
          "concept": {
            "identifier": "0017014",
            "name": "protein nitrosylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0017014 ! \"protein nitrosylation\", Cys, 800))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f376637b6150761a5a2c2d5aa34b3637",
      "variants": [
        {
          "code": "Cys",
          "concept": {
            "identifier": "0017014",
            "name": "protein nitrosylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 800
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0018126 ! \"protein hydroxylation\", Asn, 803))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "55513624834819205dc86b33fe413c04",
      "variants": [
        {
          "code": "Asn",
          "concept": {
            "identifier": "0018126",
            "name": "protein hydroxylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 803
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0018126 ! \"protein hydroxylation\", Pro, 402))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2b4934ca29e3ed25e5252282cf357e36",
      "variants": [
        {
          "code": "Pro",
          "concept": {
            "identifier": "0018126",
            "name": "protein hydroxylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 402
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(go:0018126 ! \"protein hydroxylation\", Pro, 546))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c3c5309a1f5c6b10b8df4b0eccf6d74f",
      "variants": [
        {
          "code": "Pro",
          "concept": {
            "identifier": "0018126",
            "name": "protein hydroxylation",
            "namespace": "go"
          },
          "kind": "pmod",
          "pos": 546
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, var(\"p.Lys532?\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ae8d0387f619678738238f696dc035d6",
      "variants": [
        {
          "hgvs": "p.Lys532?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1AN)",
      "concept": {
        "name": "HIF1AN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6d8d1becde78925aa097d4902e95ac7a"
    },
    {
      "bel": "p(HGNC:HTT)",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b06bc161685303d07e7b94f740920bb7"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5878ef11015a6336bfafc7255b6f926f",
      "variants": [
        {
          "concept": {
            "name": "CAG repeats",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f12d372e20d49c261fa134ab17d23cdd",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:NAA10)",
      "concept": {
        "name": "NAA10",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f14384f25177674b6b2ca5d15576ea2b"
    },
    {
      "bel": "p(HGNC:NRP1)",
      "concept": {
        "name": "NRP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "281ebbfe33238809d916d5f4b5d90d98"
    },
    {
      "bel": "p(HGNC:RWDD3)",
      "concept": {
        "name": "RWDD3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "959ef5a9b3bb6808bb34800857ef0e8f"
    },
    {
      "bel": "p(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0685a7a8e864ce5e9ee91d28f007ba7b"
    },
    {
      "bel": "p(HGNC:SLC2A3)",
      "concept": {
        "name": "SLC2A3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dfc7bd3fb30ad4a8c7a13847cdb01ba8"
    },
    {
      "bel": "p(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "706116ed914ade77428db2dcc85fff62"
    },
    {
      "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "615aac3bc7de5afe7a6d65c647adfd16",
      "variants": [
        {
          "hgvs": "Gly93Ala",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:UBE2I)",
      "concept": {
        "name": "UBE2I",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "04324d5a1da0ddb8c8aa75e7244d82e3"
    },
    {
      "bel": "p(HGNC:VEGFA)",
      "concept": {
        "name": "VEGFA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3537912f85b0c685b323cfa4aaff98c1"
    },
    {
      "bel": "p(HGNC:VHL)",
      "concept": {
        "name": "VHL",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "51ee7ec3981d10efa166f95b9b4fc8d0"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Basic helix-loop-helix proteins\")",
      "concept": {
        "name": "Basic helix-loop-helix proteins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "a948586e7556949b96089c5b831f8b61"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Mitogen-activated protein kinases\")",
      "concept": {
        "name": "Mitogen-activated protein kinases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "1d67605932fe18429a72c45866d1bb26"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"SUMO specific peptidases\")",
      "concept": {
        "name": "SUMO specific peptidases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "8b2b00d40eb190d7af500e9cbbffede9"
    },
    {
      "bel": "p(MESH:\"Hypoxia-Inducible Factor 1\")",
      "concept": {
        "name": "Hypoxia-Inducible Factor 1",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4e348c44a211012bbb3e2f65fe3081ba"
    },
    {
      "bel": "p(MESH:\"Prolyl Hydroxylases\")",
      "concept": {
        "name": "Prolyl Hydroxylases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "cca3954fb9af116baf07bf1554db6d59"
    },
    {
      "bel": "p(NCIT:C13718)",
      "concept": {
        "name": "C13718",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "543bd74118561c4ee9d67403c9b8256a"
    },
    {
      "bel": "p(NCIT:C13970)",
      "concept": {
        "name": "C13970",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "5d2ad7617b22c9e31ec98493d0d94588"
    },
    {
      "bel": "p(PFAM:PAS)",
      "concept": {
        "name": "PAS",
        "namespace": "PFAM"
      },
      "function": "Protein",
      "id": "7dbe282b6d7fc84f66da534e82961b2f"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:\"Parkinson's disease\")",
      "concept": {
        "name": "Parkinson's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "76019b99765efff85f16f73b8c6f082e"
    },
    {
      "bel": "path(DOID:\"amyotrophic lateral sclerosis\")",
      "concept": {
        "name": "amyotrophic lateral sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "c85c0e42ab7cd0643e9447a4444d00ef"
    },
    {
      "bel": "path(DOID:\"neurodegenerative disease\")",
      "concept": {
        "name": "neurodegenerative disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "9005fde45d3d20011ddb308da0266009"
    },
    {
      "bel": "path(DOID:hypoglycemia)",
      "concept": {
        "name": "hypoglycemia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "369cede7855a63b26505fa5301b08af5"
    },
    {
      "bel": "path(DOID:ischemia)",
      "concept": {
        "name": "ischemia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "0635fd8d7348483eff5fbaca8b8879d1"
    },
    {
      "bel": "path(DOID:neuropathy)",
      "concept": {
        "name": "neuropathy",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "943823133ae72d328485574207be5347"
    },
    {
      "bel": "path(EFO:\"physical activity\")",
      "concept": {
        "name": "physical activity",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "baa4509c260af69bb969f841aec8c855"
    },
    {
      "bel": "path(EFO:hypoxemia)",
      "concept": {
        "name": "hypoxemia",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "3ea85c5d80fe523ee05dec11e374fa41"
    },
    {
      "bel": "path(EFO:hypoxia)",
      "concept": {
        "name": "hypoxia",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "7b851fa11c82749104da1713c9bda8ef"
    },
    {
      "bel": "path(HP:\"Behavioral abnormality\")",
      "concept": {
        "name": "Behavioral abnormality",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "c8fef1e5030ad7c31e28a857df357d02"
    },
    {
      "bel": "path(MESH:\"Amyloid Neuropathies\")",
      "concept": {
        "name": "Amyloid Neuropathies",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c7ab8ffebf0a9a5635be4e5c59d58864"
    },
    {
      "bel": "path(MESH:\"Mitochondrial Dynamics\")",
      "concept": {
        "name": "Mitochondrial Dynamics",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e78c74d1b1e902783c97f007cd19f3dc"
    },
    {
      "bel": "path(MESH:\"Motor Disorders\")",
      "concept": {
        "name": "Motor Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2e3b041e894813b580bde665989837d0"
    },
    {
      "bel": "path(MESH:\"Neurotoxicity Syndromes\")",
      "concept": {
        "name": "Neurotoxicity Syndromes",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "74054e2d9d497286c20c13bc68742e6c"
    },
    {
      "bel": "path(MESH:Cytoprotection)",
      "concept": {
        "name": "Cytoprotection",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "776b38e1b35d02d1137c0f03b18c1290"
    },
    {
      "bel": "path(NCIT:C27988)",
      "concept": {
        "name": "C27988",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "9e6f34209a5189dbbe963802ff98ff2c"
    },
    {
      "bel": "r(HGNC:EPO)",
      "concept": {
        "name": "EPO",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "04cbe9e55170d027518f95e5eea1030d"
    },
    {
      "bel": "r(HGNC:HIF1A)",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "3013a3a1b70f5df06d604d47ce4eb76b"
    },
    {
      "bel": "r(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "9a6498745116802d48fd010bc697c04e"
    },
    {
      "bel": "r(HGNC:SLC2A3)",
      "concept": {
        "name": "SLC2A3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "7345aed57b9854e72e012b28fcb14703"
    },
    {
      "bel": "r(HGNC:TH)",
      "concept": {
        "name": "TH",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "c33c26c9805bbb35ccdf493e65829253"
    },
    {
      "bel": "r(HGNC:VEGFA)",
      "concept": {
        "name": "VEGFA",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "cc401b6f151e43641f18bb07734b2722"
    }
  ]
}